Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Retrospective Analysis of Skin/Soft Tissue Primary NK/T Cell Lymphoma
Completed
- Conditions
- Extranodal NK/T Cell Lymphoma
- First Posted Date
- 2011-04-25
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01341119
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Infections Associated With the Use of Alemtuzumab
Completed
- Conditions
- Patients Treated With Alemtuzumab
- First Posted Date
- 2011-03-15
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 182
- Registration Number
- NCT01315457
- Locations
- 🇮🇩
Cipto Mangunkusumo General Hospital, Jakarta, Indonesia
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇨🇳Queen Mary Hospital, Hong Kong, China
Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2011-03-10
- Last Posted Date
- 2011-03-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 92
- Registration Number
- NCT01312337
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer
- First Posted Date
- 2011-03-10
- Last Posted Date
- 2011-03-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 51
- Registration Number
- NCT01312311
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
Phase 2
Completed
- Conditions
- Locally Advanced Stage III or IV Thymic Cancer
- Interventions
- Drug: neoadjuvant docetaxel/cisplatin
- First Posted Date
- 2011-03-10
- Last Posted Date
- 2016-04-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 27
- Registration Number
- NCT01312324
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Phase 2
Completed
- Conditions
- Hypopharyngeal Cancer
- Interventions
- Drug: neoadjuvant docetaxel/cisplatin/fluorouracil
- First Posted Date
- 2011-03-10
- Last Posted Date
- 2019-12-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT01312350
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
Completed
- Conditions
- Patients With Diffuse Large B-cell Lymphoma or Follicular LymphomaPatients Treated With Rituximab-CHOP or Rituximab-CVP
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 600
- Registration Number
- NCT01311232
- Locations
- 🇨🇳
Queen Mary Hospital, Hing Kong, China
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇸🇬National Cancer Center, Singapore, Singapore
Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder
- First Posted Date
- 2011-03-07
- Last Posted Date
- 2013-01-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 164
- Registration Number
- NCT01309776
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷Inje University Paik Hospital, Goyang, Korea, Republic of
Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection
- First Posted Date
- 2011-03-03
- Last Posted Date
- 2011-03-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT01308177
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain Metastasis
Phase 3
- Conditions
- Nonsmall Cell Lung Cancer
- Interventions
- Radiation: RadiosurgeryRadiation: Observation
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2011-02-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 176
- Registration Number
- NCT01301560
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath